Metossiflurano [Dcit] en es it fr

Metossiflurano [Dcit] Brand names, Metossiflurano [Dcit] Analogs

Metossiflurano [Dcit] Brand Names Mixture

  • No information avaliable

Metossiflurano [Dcit] Chemical_Formula


Metossiflurano [Dcit] RX_link

No information avaliable

Metossiflurano [Dcit] fda sheet

Metossiflurano [Dcit] msds (material safety sheet)

Metossiflurano_[Dcit] MSDS

Metossiflurano [Dcit] Synthesis Reference

Miller et al., J. Am. Chem. Soc. 70, 431 (1948)

Metossiflurano [Dcit] Molecular Weight

164.965 g/mol

Metossiflurano [Dcit] Melting Point

-35 oC (melting point), 105 oC (boiling point)

Metossiflurano [Dcit] H2O Solubility

2.83E+004 mg/L

Metossiflurano [Dcit] State


Metossiflurano [Dcit] LogP


Metossiflurano [Dcit] Dosage Forms


Metossiflurano [Dcit] Indication

For use in the induction and maintenance of general anesthesia

Metossiflurano [Dcit] Pharmacology

Methoxyflurane is a general inhalation anesthetic used for induction and maintenance of general anesthesia. It induces muscle relaxation and reduces pains sensitivity by altering tissue excitability. It does so by decreasing the extent of gap junction mediated cell-cell coupling and altering the activity of the channels that underlie the action potential.

Metossiflurano [Dcit] Absorption

No information avaliable

Metossiflurano [Dcit] side effects and Toxicity

LD50=3600 mg/kg (Orally in rats). Symptoms of overexposure include eye irritation, CNS depression, analgesia, anesthesia, seizures, respiratory depression, and liver and kidney damage.

Metossiflurano [Dcit] Patient Information

No information avaliable

Metossiflurano [Dcit] Organisms Affected

Humans and other mammals